Home/Recalls/FDA-Z-1103-2026
FDA DevicesClass II

RayStation/RayPlan. Model/Catalog Numbers: 11.0.0, 11.0.1, 11.0.3, 11.0.4. Soft...

Published: January 28, 2026Recall ID: Z-1103-2026Category: devicesCountry: US

Reason for Recall / Hazard

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.

Product Description & Identification

RayStation/RayPlan. Model/Catalog Numbers: 11.0.0, 11.0.1, 11.0.3, 11.0.4. Software Version: RayStation 11A, RayStation 11A SP1, RayStation 11A SP2, RayStation 11A SP3. Radiation Therapy Treatment Planning System

Affected Products

RayStation/RayPlan. Model/Catalog Numbers: 11.0.0, 11.0.1, 11.0.3, 11.0.4. Software Version: RayStation 11A, RayStation 11A SP1, RayStation 11A SP2, RayStation 11A SP3. Radiation Therapy Treatment Planning System

Additional Source Details

FieldValue
CityStockholm
Event id98117
Address 1Eugeniavagen 18c
Code infoLot Code: UDI: 0735000201038920210518, 0735000201043320210610, 0735000201044020210916, 35000201063120220616. GTIN: 07350002010389, 07350002010433, 07350002010440, 07350002010631. Serial Numbers: 11.0.0.951, 11.0.1.29, 11.0.3.116, 11.0.4.15. Software Revision: RayStation 11A, 11A SP1, 11A SP2, 11A SP3. Expiration Date: 2027-06-22.
Postal codeN/A
Report date20260128
Product typeDevices
Product quantity10 units
Reason for recallPotential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251128
Initial firm notificationE-Mail
Center classification date20260116

Overview

  • Recalling FirmRAYSEARCH LABORATORIES AB
  • StatusOngoing
  • Risk LevelClass II
  • DistributionRefer to the attached documents: Distribution list 167168 US - updated, Distribution list 167168 OUS
Official Agency Alert